Loss of basal forebrain p75NTR immunoreactivity in subjects with mild cognitive impairment and Alzheimer's disease

Elliott J. Mufson, Shuang Y. Ma, John Dills, Elizabeth J. Cochran, Sue Leurgans, Joanne Wuu, David A. Bennett, Syed Jaffar, Michelle L. Gilmor, Alan I. Levey, Jeffrey H. Kordower

Research output: Contribution to journalArticle

174 Citations (Scopus)

Abstract

The long-held belief that degeneration of the cholinergic basal forebrain was central to Alzheimer's disease (AD) pathogenesis and occurred early in the disease process has been questioned recently. In this regard, changes in some cholinergic basal forebrain (CBF) markers (e.g. the high affinity trkA receptor) but not others (e.g., cortical choline acetyltransferase [ChAT] activity, the number of ChAT and vesicular acetylcholine transporter-immunoreactive neurons) suggest specific phenotypic changes, but not frank neuronal degeneration, early in the disease process. The present study examined the expression of the low affinity p75 neurotrophin receptor (p75NTR), an excellent marker of CBF neurons, in postmortem tissue derived from clinically well-characterized individuals who have been classified as having no cognitive impairment (NCI), mild cognitive impairment (MCI), and mild AD. Relative to NCI individuals, a significant and similar reduction in the number of nucleus basalis p75NTR-immunoreactive neurons was seen in individuals with MCI (38%) and mild AD (43%). The number of p75NTR-immunoreactive nucleus basalis neurons was significantly correlated with performance on the Mini-Mental State Exam, a Global Cognitive Test score, as well as some individual tests of working memory and attention. These data, together with previous reports, support the concept that phenotypic changes, but not frank neuronal degeneration, occur early in cognitive decline. Although there was no difference in p75NTR CBF cell reduction between MCI and AD, it remains to be determined whether these findings lend support to the hypothesis that MCI is a prodromal stage of AD.

Original languageEnglish
Pages (from-to)136-153
Number of pages18
JournalJournal of Comparative Neurology
Volume443
Issue number2
DOIs
StatePublished - Feb 4 2002
Externally publishedYes

Fingerprint

Nerve Growth Factor Receptor
Alzheimer Disease
Cholinergic Agents
Neurons
Choline O-Acetyltransferase
Vesicular Acetylcholine Transport Proteins
trkA Receptor
Prodromal Symptoms
Cognitive Dysfunction
Basal Forebrain
Short-Term Memory

Keywords

  • Alzheimer's disease
  • Cholinergic
  • Dementia
  • Neurotrophin receptor
  • Nucleus basalis
  • Stereology

ASJC Scopus subject areas

  • Neuroscience(all)

Cite this

Loss of basal forebrain p75NTR immunoreactivity in subjects with mild cognitive impairment and Alzheimer's disease. / Mufson, Elliott J.; Ma, Shuang Y.; Dills, John; Cochran, Elizabeth J.; Leurgans, Sue; Wuu, Joanne; Bennett, David A.; Jaffar, Syed; Gilmor, Michelle L.; Levey, Alan I.; Kordower, Jeffrey H.

In: Journal of Comparative Neurology, Vol. 443, No. 2, 04.02.2002, p. 136-153.

Research output: Contribution to journalArticle

Mufson, EJ, Ma, SY, Dills, J, Cochran, EJ, Leurgans, S, Wuu, J, Bennett, DA, Jaffar, S, Gilmor, ML, Levey, AI & Kordower, JH 2002, 'Loss of basal forebrain p75NTR immunoreactivity in subjects with mild cognitive impairment and Alzheimer's disease', Journal of Comparative Neurology, vol. 443, no. 2, pp. 136-153. https://doi.org/10.1002/cne.10122
Mufson, Elliott J. ; Ma, Shuang Y. ; Dills, John ; Cochran, Elizabeth J. ; Leurgans, Sue ; Wuu, Joanne ; Bennett, David A. ; Jaffar, Syed ; Gilmor, Michelle L. ; Levey, Alan I. ; Kordower, Jeffrey H. / Loss of basal forebrain p75NTR immunoreactivity in subjects with mild cognitive impairment and Alzheimer's disease. In: Journal of Comparative Neurology. 2002 ; Vol. 443, No. 2. pp. 136-153.
@article{9aafb5f3545942b9befa439d7c2f516e,
title = "Loss of basal forebrain p75NTR immunoreactivity in subjects with mild cognitive impairment and Alzheimer's disease",
abstract = "The long-held belief that degeneration of the cholinergic basal forebrain was central to Alzheimer's disease (AD) pathogenesis and occurred early in the disease process has been questioned recently. In this regard, changes in some cholinergic basal forebrain (CBF) markers (e.g. the high affinity trkA receptor) but not others (e.g., cortical choline acetyltransferase [ChAT] activity, the number of ChAT and vesicular acetylcholine transporter-immunoreactive neurons) suggest specific phenotypic changes, but not frank neuronal degeneration, early in the disease process. The present study examined the expression of the low affinity p75 neurotrophin receptor (p75NTR), an excellent marker of CBF neurons, in postmortem tissue derived from clinically well-characterized individuals who have been classified as having no cognitive impairment (NCI), mild cognitive impairment (MCI), and mild AD. Relative to NCI individuals, a significant and similar reduction in the number of nucleus basalis p75NTR-immunoreactive neurons was seen in individuals with MCI (38{\%}) and mild AD (43{\%}). The number of p75NTR-immunoreactive nucleus basalis neurons was significantly correlated with performance on the Mini-Mental State Exam, a Global Cognitive Test score, as well as some individual tests of working memory and attention. These data, together with previous reports, support the concept that phenotypic changes, but not frank neuronal degeneration, occur early in cognitive decline. Although there was no difference in p75NTR CBF cell reduction between MCI and AD, it remains to be determined whether these findings lend support to the hypothesis that MCI is a prodromal stage of AD.",
keywords = "Alzheimer's disease, Cholinergic, Dementia, Neurotrophin receptor, Nucleus basalis, Stereology",
author = "Mufson, {Elliott J.} and Ma, {Shuang Y.} and John Dills and Cochran, {Elizabeth J.} and Sue Leurgans and Joanne Wuu and Bennett, {David A.} and Syed Jaffar and Gilmor, {Michelle L.} and Levey, {Alan I.} and Kordower, {Jeffrey H.}",
year = "2002",
month = "2",
day = "4",
doi = "10.1002/cne.10122",
language = "English",
volume = "443",
pages = "136--153",
journal = "Journal of Comparative Neurology",
issn = "0021-9967",
publisher = "Wiley-Liss Inc.",
number = "2",

}

TY - JOUR

T1 - Loss of basal forebrain p75NTR immunoreactivity in subjects with mild cognitive impairment and Alzheimer's disease

AU - Mufson, Elliott J.

AU - Ma, Shuang Y.

AU - Dills, John

AU - Cochran, Elizabeth J.

AU - Leurgans, Sue

AU - Wuu, Joanne

AU - Bennett, David A.

AU - Jaffar, Syed

AU - Gilmor, Michelle L.

AU - Levey, Alan I.

AU - Kordower, Jeffrey H.

PY - 2002/2/4

Y1 - 2002/2/4

N2 - The long-held belief that degeneration of the cholinergic basal forebrain was central to Alzheimer's disease (AD) pathogenesis and occurred early in the disease process has been questioned recently. In this regard, changes in some cholinergic basal forebrain (CBF) markers (e.g. the high affinity trkA receptor) but not others (e.g., cortical choline acetyltransferase [ChAT] activity, the number of ChAT and vesicular acetylcholine transporter-immunoreactive neurons) suggest specific phenotypic changes, but not frank neuronal degeneration, early in the disease process. The present study examined the expression of the low affinity p75 neurotrophin receptor (p75NTR), an excellent marker of CBF neurons, in postmortem tissue derived from clinically well-characterized individuals who have been classified as having no cognitive impairment (NCI), mild cognitive impairment (MCI), and mild AD. Relative to NCI individuals, a significant and similar reduction in the number of nucleus basalis p75NTR-immunoreactive neurons was seen in individuals with MCI (38%) and mild AD (43%). The number of p75NTR-immunoreactive nucleus basalis neurons was significantly correlated with performance on the Mini-Mental State Exam, a Global Cognitive Test score, as well as some individual tests of working memory and attention. These data, together with previous reports, support the concept that phenotypic changes, but not frank neuronal degeneration, occur early in cognitive decline. Although there was no difference in p75NTR CBF cell reduction between MCI and AD, it remains to be determined whether these findings lend support to the hypothesis that MCI is a prodromal stage of AD.

AB - The long-held belief that degeneration of the cholinergic basal forebrain was central to Alzheimer's disease (AD) pathogenesis and occurred early in the disease process has been questioned recently. In this regard, changes in some cholinergic basal forebrain (CBF) markers (e.g. the high affinity trkA receptor) but not others (e.g., cortical choline acetyltransferase [ChAT] activity, the number of ChAT and vesicular acetylcholine transporter-immunoreactive neurons) suggest specific phenotypic changes, but not frank neuronal degeneration, early in the disease process. The present study examined the expression of the low affinity p75 neurotrophin receptor (p75NTR), an excellent marker of CBF neurons, in postmortem tissue derived from clinically well-characterized individuals who have been classified as having no cognitive impairment (NCI), mild cognitive impairment (MCI), and mild AD. Relative to NCI individuals, a significant and similar reduction in the number of nucleus basalis p75NTR-immunoreactive neurons was seen in individuals with MCI (38%) and mild AD (43%). The number of p75NTR-immunoreactive nucleus basalis neurons was significantly correlated with performance on the Mini-Mental State Exam, a Global Cognitive Test score, as well as some individual tests of working memory and attention. These data, together with previous reports, support the concept that phenotypic changes, but not frank neuronal degeneration, occur early in cognitive decline. Although there was no difference in p75NTR CBF cell reduction between MCI and AD, it remains to be determined whether these findings lend support to the hypothesis that MCI is a prodromal stage of AD.

KW - Alzheimer's disease

KW - Cholinergic

KW - Dementia

KW - Neurotrophin receptor

KW - Nucleus basalis

KW - Stereology

UR - http://www.scopus.com/inward/record.url?scp=0037016848&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0037016848&partnerID=8YFLogxK

U2 - 10.1002/cne.10122

DO - 10.1002/cne.10122

M3 - Article

C2 - 11793352

AN - SCOPUS:0037016848

VL - 443

SP - 136

EP - 153

JO - Journal of Comparative Neurology

JF - Journal of Comparative Neurology

SN - 0021-9967

IS - 2

ER -